Abstract:Necrotic enteritis (NE), caused by Clostridium perfringens , is an economically important disease in the broiler. Among normal flora in the broiler intestinal region, Clostridium butyricum has been identified as a probiotic agent that reduces the susceptibility of broilers to C. perfringens . However, the effects of C. butyricum supplement on broiler intestinal integrity during NE are largely unknown. In this study, we investigated the effects of C. butyricum on the growth performance, intestinal morphology and barrier function, and the functions of immune-related cytokines under NE in broilers. Chickens were divided into five groups: control group (NC), supplement C. butyricum only group (CB), NE-infected group (PC), supplement C. butyricum from Day 14 (NECB1) to Day 22 NE-infected group, and supplement C. butyricum from Day 1 (NECB2) to Day 22 NE-infected group. The results showed that there were significantly decreased average daily weight gain and increased feed conversion rate in the infected group (PC) compared with the C. butyricum -supplemented groups (NECB1 and NECB2) through the diet. Histopathological observation on the Hematoxylin–Eosin staining avian small intestine sections revealed that supplementation of C. butyricum (NECB1 and NECB2) could increase the intestinal villus height/crypt depth and lessen the intestinal damage under NE. ELISA and Limulus test showed that broilers infected with NE (PC) had higher serum IgA and lipopolysaccharide content; however, after C. butyricum supplementation (NECB1 and NECB2), they returned to a normal level. Furthermore, real-time PCR and Western blot results indicated that compared with PC, supplementing C. butyricum (NECB1 and NECB2) could initialize the expressions of genes related to the intestinal barrier-associated molecules (such as CLDN-1, CLDN-3, OCLN, MUC2, ZO-1, and CLDN5), cytokines (such as IL-10, IL-6, and TGFB1), and C. perfringens plc gene expression. Moreover, the results detected by the Ussing chamber suggested that C. butyricum (NECB1 and NECB2) could amend the decrease in conductivity value and short-circuit current value caused by NE. In addition, NECB2 significantly reduced the upregulation of fluorescein isothiocyanate–dextran flux caused by the NE disease. In conclusion, these findings suggest that dietary supplementation of C. butyricum in broilers with NE improved chicken growth performance, intestinal integrity and barrier function, and immunological status. Notably, no statistical difference was observed with the addition of C. butyricum on day 1 or day 14.

Analysis of immunomodulation to intestinal inflammatory injury in chickens caused by Clostridium perfringens C57-1 infection

Transcriptomic and Proteomic Analysis of the Jejunum Revealed the Effects and Mechanism of Protocatechuic Acid on Alleviating Salmonella Typhimurium Infection in Chickens

Identification of Changes in the Composition of Ileal Bacterial Microbiota of Broiler Chickens Infected with Clostridium Perfringens

Inflammatory Responses to a Clostridium Perfringens Type A Strain and Α-Toxin in Primary Intestinal Epithelial Cells of Chicken Embryos.

The Effect of Clostridium butyricum on Gut Microbiota, Immune Response and Intestinal Barrier Function During the Development of Necrotic Enteritis in Chickens

<i>Clostridium perfringens</i>-Induced Host-Pathogen Transcriptional Changes in the Small Intestine of Broiler Chickens

Treatment of chickens with lactobacilli prior to challenge with Clostridium perfringens modifies innate responses and gut morphology

Effect of Porcine Clostridium Perfringens on Intestinal Barrier, Immunity, and Quantitative Analysis of Intestinal Bacterial Communities in Mice.

Expression Profiles of Genes in Toll-Like Receptor-Mediated Signaling of Broilers Infected with Clostridium Perfringens

Reduced Lesions in Chickens with Clostridium Perfringens-Induced Necrotic Enteritis by Lactobacillus Fermentum 1.2029

Exogenous Lysozyme Influences Clostridium Perfringens Colonization and Intestinal Barrier Function in Broiler Chickens.

Ex Vivo Differential Responsiveness to Clostridium perfringens and Lactococcus lactis by Avian Small Intestine Macrophages and T Cells

In vivo overexpression of the avian interleukin-17 in a necrotic enteritis disease model modulates the expression of antimicrobial peptides in the small intestine of broilers

Effects of dietary Clostridium butyricum supplementation on growth performance, intestinal barrier function, immune response, and intestinal permeability in broiler chickens with necrotic enteritis

Identification of immunogenic antigens and evaluation of vaccine candidates against Clostridium perfringens

In Vivo and in Vitro Protective Effect Ofarginine Against Intestinal Inflammatory Response Induced by Clostridium Perfringens in Broiler Chickens

Host responses to Clostridium perfringens challenge in a chicken model of chronic stress

Clostridium butyricum Supplement Can Ameliorate the Intestinal Barrier Roles in Broiler Chickens Experimentally Infected With Clostridium perfringens

Disruption in the Cecal Microbiota of Chickens Challenged with Clostridium Perfringens and Other Factors Was Alleviated by Bacillus Licheniformis Supplementation.

In vivo and in vitro protective effect of arginine against intestinal inflammatory response induced by Clostridium perfringens in broiler chickens

<i>Clostridium butyricum</i> Supplement Can Ameliorate the Intestinal Barrier Roles in Broiler Chickens Experimentally Infected With <i>Clostridium perfringens</i>